These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 32119801)

  • 61. The metabolic syndrome and cardiovascular disease: Part I.
    Jiamsripong P; Mookadam M; Honda T; Khandheria BK; Mookadam F
    Prev Cardiol; 2008; 11(3):155-61. PubMed ID: 18607151
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The relationship of ectopic lipid accumulation to cardiac and vascular function in obesity and metabolic syndrome.
    Ruberg FL; Chen Z; Hua N; Bigornia S; Guo Z; Hallock K; Jara H; LaValley M; Phinikaridou A; Qiao Y; Viereck J; Apovian CM; Hamilton JA
    Obesity (Silver Spring); 2010 Jun; 18(6):1116-21. PubMed ID: 19875992
    [TBL] [Abstract][Full Text] [Related]  

  • 63. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE.
    Jellinger PS; Handelsman Y; Rosenblit PD; Bloomgarden ZT; Fonseca VA; Garber AJ; Grunberger G; Guerin CK; Bell DSH; Mechanick JI; Pessah-Pollack R; Wyne K; Smith D; Brinton EA; Fazio S; Davidson M
    Endocr Pract; 2017 Apr; 23(Suppl 2):1-87. PubMed ID: 28437620
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Atherogenic Dyslipidemia and Residual Vascular Risk in Practice of Family Doctor.
    Alibasic E; Ramic E; Bajraktarevic A; Ljuca F; Batic-Mujanovic O; Zildzic M
    Med Arch; 2015 Oct; 69(5):339-41. PubMed ID: 26622090
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Risk factors related to cardiovascular diseases and the metabolic syndrome in multiple sclerosis - a systematic review.
    Wens I; Dalgas U; Stenager E; Eijnde BO
    Mult Scler; 2013 Oct; 19(12):1556-64. PubMed ID: 24048545
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Angiotensin receptor-binding protein ATRAP/Agtrap inhibits metabolic dysfunction with visceral obesity.
    Maeda A; Tamura K; Wakui H; Dejima T; Ohsawa M; Azushima K; Kanaoka T; Uneda K; Matsuda M; Yamashita A; Miyazaki N; Yatsu K; Hirawa N; Toya Y; Umemura S
    J Am Heart Assoc; 2013 Jul; 2(4):e000312. PubMed ID: 23902639
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Use of BMI as the marker of adiposity in a metabolic syndrome severity score: Derivation and validation in predicting long-term disease outcomes.
    Gurka MJ; Filipp SL; Musani SK; Sims M; DeBoer MD
    Metabolism; 2018 Jun; 83():68-74. PubMed ID: 29410278
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Follicle-Stimulating Hormone, Its Association with Cardiometabolic Risk Factors, and 10-Year Risk of Cardiovascular Disease in Postmenopausal Women.
    Wang N; Shao H; Chen Y; Xia F; Chi C; Li Q; Han B; Teng Y; Lu Y
    J Am Heart Assoc; 2017 Aug; 6(9):. PubMed ID: 28855169
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Adiposopathy, "sick fat," Ockham's razor, and resolution of the obesity paradox.
    Bays H
    Curr Atheroscler Rep; 2014 May; 16(5):409. PubMed ID: 24659222
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Obesity and dyslipidemia in South Asians.
    Misra A; Shrivastava U
    Nutrients; 2013 Jul; 5(7):2708-33. PubMed ID: 23863826
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Biglycan and atherosclerosis: Lessons from high cardiovascular risk conditions.
    Scuruchi M; Potì F; Rodríguez-Carrio J; Campo GM; Mandraffino G
    Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Feb; 1865(2):158545. PubMed ID: 31672572
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.
    Nesto RW
    Am J Cardiovasc Drugs; 2005; 5(6):379-87. PubMed ID: 16259526
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Adipose tissue and atherosclerosis: exploring the connection.
    Fantuzzi G; Mazzone T
    Arterioscler Thromb Vasc Biol; 2007 May; 27(5):996-1003. PubMed ID: 17303782
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Pathogenesis and management of the dyslipidemia of the metabolic syndrome.
    Raal FJ
    Metab Syndr Relat Disord; 2009 Apr; 7(2):83-8. PubMed ID: 19400742
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The relationships of plasma adiponectin with a favorable lipid profile, decreased inflammation, and less ectopic fat accumulation depend on adiposity.
    Kantartzis K; Rittig K; Balletshofer B; Machann J; Schick F; Porubska K; Fritsche A; Häring HU; Stefan N
    Clin Chem; 2006 Oct; 52(10):1934-42. PubMed ID: 16916991
    [TBL] [Abstract][Full Text] [Related]  

  • 76. PPAR Agonists, Atherogenic Dyslipidemia and Cardiovascular Risk.
    Nikolic D; Castellino G; Banach M; Toth PP; Ivanova E; Orekhov AN; Montalto G; Rizzo M
    Curr Pharm Des; 2017 Mar; 23(6):894-902. PubMed ID: 27719644
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Ectopic fat accumulation and metabolic syndrome.
    Rasouli N; Molavi B; Elbein SC; Kern PA
    Diabetes Obes Metab; 2007 Jan; 9(1):1-10. PubMed ID: 17199713
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Characterization and LDL-C management in a cohort of high and very high cardiovascular risk patients: The PORTRAIT-DYS study.
    Gavina C; Seabra-Carvalho D; Aguiar C; Anastassopoulou A; Teixeira C; Ruivo JA; Almeida É; Luz-Duarte L; Corte-Real A; Canelas-Pais M; Taveira-Gomes T
    Clin Cardiol; 2024 Jan; 47(1):e24183. PubMed ID: 37933175
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Visceral adiposity and its anatomical distribution as predictors of the metabolic syndrome and cardiometabolic risk factor levels.
    Demerath EW; Reed D; Rogers N; Sun SS; Lee M; Choh AC; Couch W; Czerwinski SA; Chumlea WC; Siervogel RM; Towne B
    Am J Clin Nutr; 2008 Nov; 88(5):1263-71. PubMed ID: 18996861
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey.
    Kones R
    Drug Des Devel Ther; 2011; 5():325-80. PubMed ID: 21792295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.